From Eleven Biotherapeutics Raises $20M to Advance Dry-Eye Drug:

ElevenBioSizedLogo

ElevenBioSizedLogo—

Eleven Biotherapeutics is developing a treatment for dry eye.

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!